|
Volumn 30, Issue 3, 2020, Pages 269-271
|
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE PHOSPHATE;
ALANINE;
ANTIMALARIAL AGENT;
ANTIVIRUS AGENT;
CHLOROQUINE;
CHOLECYSTOKININ OCTAPEPTIDE;
COVID-19;
REMDESIVIR;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
ANIMAL;
BETACORONAVIRUS;
BIOASSAY;
CHLOROCEBUS AETHIOPS;
CORONAVIRUS DISEASE 2019;
CORONAVIRUS INFECTION;
DRUG DEVELOPMENT;
DRUG EFFECT;
HUMAN;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
PATHOGENICITY;
PRECLINICAL STUDY;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
VERO CELL LINE;
VIRUS PNEUMONIA;
ADENOSINE MONOPHOSPHATE;
ALANINE;
ANIMALS;
ANTIMALARIALS;
ANTIVIRAL AGENTS;
BETACORONAVIRUS;
BIOLOGICAL ASSAY;
CHLOROCEBUS AETHIOPS;
CHLOROQUINE;
CORONAVIRUS INFECTIONS;
DRUG DISCOVERY;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
PNEUMONIA, VIRAL;
SARS VIRUS;
SINCALIDE;
VERO CELLS;
|
EID: 85079126550
PISSN: 10010602
EISSN: 17487838
Source Type: Journal
DOI: 10.1038/s41422-020-0282-0 Document Type: Letter |
Times cited : (5478)
|
References (11)
|